Drug intelligence / Profile preview

UFZ-HM

Development stage
Preclinical
Lead developer
Affiliated Hospital of Nantong University
Modality
Small Molecules, Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

UFZ-HM is a biomimetic, pH-responsive nanoparticle system designed for the targeted treatment of glioblastoma (GBM). It consists of a zeolitic imidazolate framework-8 (ZIF-8) core loaded with ursolic acid (UA) and iron oxide (Fe₃O₄) nanoparticles, coated with a hybrid membrane derived from neutrophils and glioma cells. The hybrid membrane coating provides dual-targeting capabilities through inflammatory chemotaxis (via the neutrophil membrane) and homologous recognition (via the glioma membrane), enabling the nanoparticles to cross the blood-brain barrier (BBB) and target residual glioma cells. In the acidic tumor microenvironment, the ZIF-8 framework degrades to release its cargo. Ursolic acid induces tumor cell apoptosis, while Fe₃O₄ triggers ferroptosis via the Fenton reaction, resulting in synergistic anti-tumor efficacy.

Beyond the preview

Go deeper on UFZ-HM.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UFZ-HM.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call